| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/29/2001 | CA2383591A1 Cell based assay |
| 03/29/2001 | CA2383462A1 Therapeutic methods and compounds |
| 03/29/2001 | CA2383274A1 Solid phase assay |
| 03/29/2001 | CA2379628A1 Method to study insulin action |
| 03/29/2001 | CA2350700A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/29/2001 | CA2319213A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 03/28/2001 | EP1087230A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/28/2001 | EP1087226A1 Gas analyzer and method of calibrating the same |
| 03/28/2001 | EP1087223A1 Analyzer |
| 03/28/2001 | EP1087020A2 Universal probes and methods for detection of nucleic acids |
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1086956A1 Gene recombinant antibodies |
| 03/28/2001 | EP1086494A1 Infrared thermography |
| 03/28/2001 | EP1086378A1 Analytical method using multiple virus labelling |
| 03/28/2001 | EP1086377A1 A method of identifying ligands to rna polymerase sigma 70 subunit |
| 03/28/2001 | EP1086376A1 Inflammatory bowel disease first step assay system |
| 03/28/2001 | EP1086375A1 Colloidal colorimetric flow through and lateral flow assays utilizing soluble submicron particles |
| 03/28/2001 | EP1086374A1 Detection of ligands with signal amplification |
| 03/28/2001 | EP1086372A1 Collection device for single step assay of oral fluids |
| 03/28/2001 | EP1086370A1 Detector for one or several polluting gases and use thereof |
| 03/28/2001 | EP1086364A1 Electrochemical analytical cartridge |
| 03/28/2001 | EP1086363A1 Automatic analysis apparatus used for timing blood coagulation |
| 03/28/2001 | EP1086353A1 Method and apparatus for determining processing chamber cleaning or wafer etching endpoint |
| 03/28/2001 | EP1086252A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt) |
| 03/28/2001 | EP1086242A1 Fluorescent assay for topoisomerase inhibitors |
| 03/28/2001 | EP1086241A1 Non-viable cell preparation and assay reagent |
| 03/28/2001 | EP1086240A1 Methods for testing biological network models |
| 03/28/2001 | EP1086238A1 Human mp52 gene promoter and method for exploring useful substance by using the same |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin |
| 03/28/2001 | EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/28/2001 | EP1086221A2 Truncated apaf-1 and methods of use thereof |
| 03/28/2001 | EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer |
| 03/28/2001 | EP1086217A2 Novel angiotensin receptor, production and use thereof |
| 03/28/2001 | EP1086215A2 Preparation and use of superior vaccines |
| 03/28/2001 | EP1086205A1 Methods of monitoring disease states and therapies using gene expression profiles |
| 03/28/2001 | EP1086179A1 Energy transfer assay method and reagent |
| 03/28/2001 | EP1086178A1 An anthraquinone and its derivatives |
| 03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 03/28/2001 | EP1086137A1 Composition and method for modulating dendritic cell-t cell interaction |
| 03/28/2001 | EP1086136A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples |
| 03/28/2001 | EP1086135A2 "monoclonal anitbody and assay for detecting n-terminal procollagen (iii) propeptide (piiinp)" |
| 03/28/2001 | EP1086123A1 Solution-phase elisa |
| 03/28/2001 | EP1086122A1 Pyrazinone protease inhibitors |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086063A1 Novel potassium channel drugs and their uses |
| 03/28/2001 | EP1085943A1 Three-dimensional array of supports for solid-phase parallel synthesis and method of use |
| 03/28/2001 | EP1085903A1 Egg surface proteins and methods for use for modulating fertility |
| 03/28/2001 | EP1085899A1 Retinoic acid inducible dna sequences from lung cells |
| 03/28/2001 | EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/28/2001 | EP1085895A1 Bradykinin antagonists |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085890A1 Novel sodium channel drugs and uses |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085888A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht 3? receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085885A2 Method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition |
| 03/28/2001 | EP1085879A2 Multibinding agents that modulate the 5-ht transporter |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085863A1 Cross-reference to related applications |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP1045764A4 Labeling technique for countering product diversion and product counterfeiting |
| 03/28/2001 | EP0920625B1 Active substance screening process |
| 03/28/2001 | EP0659275B1 Analytical test apparatus with on board negative and positive control |
| 03/28/2001 | EP0621946B1 Apparatus and method for textile sample testing |
| 03/28/2001 | EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof |
| 03/28/2001 | CN2425364Y Concrete integrald tester |
| 03/28/2001 | CN2425359Y Laser diffraction differential blood cells counting instrument |
| 03/28/2001 | CN1289409A PAI-2 and t-PA as diagnostic markers of periodontal disease |
| 03/28/2001 | CN1289369A Riboflavin biosynthesis genes from plants and uses thereof |
| 03/28/2001 | CN1289045A Active organism probe and its making process and use |
| 03/28/2001 | CN1288955A Multielement protein chip and its preparation and application |
| 03/27/2001 | US6208941 Method and apparatus for analysis of chromatographic migration patterns |
| 03/27/2001 | US6208940 Cone tipped cylindrical probe for use in groundwater testing |
| 03/27/2001 | US6208420 Method and apparatus for estimating quality of grains |
| 03/27/2001 | US6208256 Automobile carbon monoxide detection and control device |
| 03/27/2001 | US6207831 A benzopyrazole compound |
| 03/27/2001 | US6207818 Amplification and detection of shigella spp. and enteroinvasive strains of Escherichia coli |
| 03/27/2001 | US6207816 High affinity oligonucleotide ligands to growth factors |
| 03/27/2001 | US6207812 Chondrosarcoma associated genes |
| 03/27/2001 | US6207811 Nephrin gene and protein |
| 03/27/2001 | US6207807 Immobilizing a peptide which binds to fc region of antibody onto an affinity chromatography support, packing into column, equilibrating with buffer, applying solution to column, washing with eluent to remove impurites, eluting antibodies |
| 03/27/2001 | US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207645 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
| 03/27/2001 | US6207464 Incubating target with dye to form a covalent bond; blue fluorescing dyes |
| 03/27/2001 | US6207463 Elongated magnet at lower end with ferromagnetic arm attached to magnet and an elongated, movable protective cover with tip; particles accumulate on tip of cover; cover is movable for release of particles; materials handling |
| 03/27/2001 | US6207462 Accurate, efficient method for paving materials; heating furnace with preweighed sample and container using microwave radiation, several air draws to moderate temperature and increase rate of combustion, and reweighing |
| 03/27/2001 | US6207460 System includes converter, detector, primary channel for delivering target gas sample through converter to detector, and scrubbing channels for delivering reference gas through converter to detector; semiconductor manufacturing |
| 03/27/2001 | US6207459 Method for the analysis of medical samples containing haemoglobin |